Outcomes of Patients with RET Fusion-Positive Non-Small Cell Lung Cancer Treated with First-Line Non-Molecularly Targeted Therapies: A Real-World Benchmark in Europe from the RECALIB-RET Study.
| Publicado en: | Advances in Therapy Vol. 43; no. 8; pp. 3568 - 3587 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Aug2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Descripción no disponible. |